US FDA approves Pfizer's Inlyta for kidney cancer

www.reuters.com: : WASHINGTON (Reuters) - Pfizer's Inlyta drug for patients with advanced kidney cancer got the nod from U.S. regulators on Friday, boosting the company's plans to offset plunging Lipitor sales.The Food



7 people shared this link in the last 24 hours.

11 people shared this quote till date.

Related Articles

  • FDA Approves New Suppliers to Ease Cancer Drug Shortages

    healthland.time.com
    Shared 3 times

    Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages — at least for the time being — that have left patients and parents frightened about missing life-saving treatments.

  • F.D.A. Approves Imports Amid Shortage of 2 Cancer Drugs

    www.allvoices.com
    Shared once

    Dire shortages of two critical cancer drugs shortfalls that have threatened the lives and care of thousands of cancer patients should be resolved within weeks, federal drug officials said. The

  • Pfizer reportedly weighing animal health IPO - FiercePharma

    www.fiercepharma.com
    Shared once

    Pfizer isn't saying much about its divestment plans. But that doesn't stop other people from talking. The latest? An IPO for the animal-health division, reported by the Financial Times. The Read more...

  • FDA acts to stem shortages of two cancer drugs

    www.reuters.com
    Shared 11 times

    (Reuters) - The Food and Drug Administration is addressing the U.S. shortage of critical cancer medications by importing one drug from abroad and rushing the approval of another.The move announced on

  • FDA: New suppliers to ease 2 cancer drug shortages

    www.kimatv.com
    Shared 3 times

    Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages - at least for the time being - that have patients worried about missing life-saving treatments.

Top Links

blog comments powered by Disqus